The role of dysfunctional HDL in atherosclerosis

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Inflammation Biology

Background:

• High-density lipoprotein (HDL) plays a crucial role in lipid metabolism and possesses anti-inflammatory properties.
• Dysfunctional HDL is implicated in chronic inflammatory conditions, notably atherosclerosis.
• Loss of HDL's anti-inflammatory function often parallels impaired reverse cholesterol transport.

Purpose of the Study:

• To review the role of HDL in regulating low-density lipoprotein (LDL) oxidation and LDL-induced inflammation.
• To explore the mechanisms underlying HDL dysfunction in inflammatory diseases.
• To discuss potential therapeutic strategies for restoring HDL function.

Main Methods:

• Literature review of studies on HDL function, LDL oxidation, and inflammation.
• Analysis of data from animal models and human studies of atherosclerosis.
• Examination of the effects of apoA-I mimetic peptides on HDL function.

Main Results:

• Dysfunctional HDL is associated with increased LDL oxidation and inflammation in atherosclerosis.
• Impaired reverse cholesterol transport is a hallmark of dysfunctional HDL.
• ApoA-I mimetic peptides demonstrate potential in improving HDL function by targeting oxidized lipids.

Conclusions:

• HDL dysfunction contributes significantly to the pathogenesis of atherosclerosis.
• Restoring HDL's anti-inflammatory and cholesterol-efflux capacities is a key therapeutic goal.
• ApoA-I mimetic peptides represent a promising therapeutic avenue for managing HDL dysfunction.